United Therapeutics buy UBS Group AG
Start price
08.07.24
/
50%
€292.80
Target price
08.07.25
€341.51
Performance (%)
-15.78%
Price
01.07.25
€246.60
This prediction will end soon
Summary
This prediction is currently active. The prediction for United Therapeutics disappoints with a performance of -15.78%. This prediction currently runs until 08.07.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | -1.321% | -1.321% |
| iShares Core DAX® | -0.081% | -1.435% |
| iShares Nasdaq 100 | -0.201% | 1.543% |
| iShares Nikkei 225® | 1.465% | 1.838% |
| iShares S&P 500 | 0.215% | 1.237% |
Comments by UBS_Group_AG for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at UBS Group AG from $300.00 to $370.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by UBS_Group_AG for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€244.10
30.06.25
30.06.25
€328.48
30.06.26
30.06.26
1.02%
01.07.25
01.07.25
United Therapeutics
Start price
Target price
Perf. (%)
€355.30
08.01.25
08.01.25
€460.94
08.01.26
08.01.26
-30.59%
01.07.25
01.07.25